We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wanda and Dignity Health to Launch Digital Health Platform

By HospiMedica International staff writers
Posted on 14 Mar 2016
Wanda (San Francisco, CA, USA) has signed a deal with a Dignity Health (San Francisco, CA, USA) to launch a digital health oncology care platform that will enable medical professionals to make informed oncological treatment decisions.

The OncoVerse digital healthcare platform will enable care teams to collaborate in real time, across all disciplines, in order to determine the most effective treatment plan for cancer patients. More...
The virtual care collaboration platform enables unprecedented information-sharing capabilities through geographically dispersed, structured collaboration of the multidisciplinary care team, expanding the reach of clinical decision-making support to rural and remote areas, thus enabling patients in those locations to benefit from insights previously only shared at large medical centers.

The digital healthcare platform also allows medical professionals to highlight cancer-related cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device. Wanda is a NetScientific (London, United Kingdom) portfolio company. NetScientific is a transatlantic biomedical and healthcare group that funds, develops, and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the USA and Europe with a primary focus on digital health, diagnostics and therapeutics.

“OncoVerse will streamline and support the decision making processes of Dignity Health's physicians and other supporting health care professionals by ensuring that the entire care team has the right information at the right time, which reinforces the power of personalized medicine,” said Steve Curd, CEO of Wanda. “As cancer therapies continue to advance, facilitating individualized cancer decision support is well-aligned with Wanda's mission: improving the efficiency and effectiveness of the management of chronic conditions.”

“Dignity Health is committed to developing partnerships that harness the tremendous potential of technology to help providers and patients make better day-to-day decisions about care,” said Costanzo DiPerna, MD, medical director for the Dignity Health Cancer Institute of the Greater Sacramento region and chief of thoracic surgery. “We are excited to work with Wanda and deliver on our vision to provide the highest quality patient care.”

OncoVerse was initially conceived by a Dignity Health physician who wanted a tool to improve team collaboration, especially when evaluating a complex cancer case and determining the appropriate treatment plan. Dignity Health engaged Wanda to develop the software due to the company's proven track record to support informed treatment decisions, and to reduce administrative costs. Wanda and Dignity Health intend to jointly market the Oncoverse platform to other oncology programs across the US later in 2016.

Related Links:

Wanda
Dignity Health
NetScientific



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Infusion System
SIGMA Spectrum
New
Pediatric Cast Saw
CSP-201 Quietcast
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.